Currently out of the existing stock ratings of Tazeen Ahmad, 130 are a BUY (60.19%), 54 are a HOLD (25%), 32 are a SELL (14.81%).

Tazeen Ahmad

Work Performance Price Targets & Ratings Chart

Analyst Tazeen Ahmad works at BAML with a stock forecast success ratio of 55.85% fulfilled within 145.12 days on average.

Tazeen Ahmad’s has documented 427 price targets and ratings displayed on 43 stocks. The coverage is on Healthcare, Industrials sectors.

Most recent stock forecast was given on FATE, Fate Therapeutics at 28-Mar-2024.

Wall Street Analyst Tazeen Ahmad

Analyst best performing recommendations are on GRTX (GALERA THERAPEUTICS).
The best stock recommendation documented was for GRTX (GALERA THERAPEUTICS) at 12/14/2021. The price target of $4 was fulfilled within 7 days with a profit of $1.3 (48.15%) receiving and performance score of 68.78.

Average potential price target upside

ACAD ACADIA Pharmaceuticals ALNY Alnylam Pharmaceuticals BNTX BioNTech SE FOLD Amicus Therapeutics FULC Fulcrum Therapeutics GRTX Galera Therapeutics GWPH GW Pharmaceuticals plc INCY yte NBIX Neurocrine Biosciences PRLD Prelude Therapeutics  PTCT PTC Therapeutics RARE Ultragenyx RYTM Rhythm Pharmaceuticals SAGE Sage Therapeutic ASND Ascendis Pharma AS CRTX Cortexyme ORPH Orphazyme A/S SRPT Sarepta Therapeutics BCRX BioCryst Pharmaceuticals PRTA Prothena plc SRZN Surrozen TBPH Theravance Biopharma ADCT ADC Therapeutics SA FATE Fate Therapeutics ADMS Adamas Pharmaceuticals AKUS Akouos  ARGX argenx NV ADR CLVS Clovis Oncology CYT Cyteir Therapeutics ETN Eaton PLC KALA Kala Pharmaceuticals MCRB Seres Therapeutics PYXS Pyxis Oncology SGEN Seagen SQZ Sqz Biotechnologies Co ZGNX Zogenix ANNX Annexon  ARVN Arvinas PRAX Praxis Precision Medicines  ACHL Achilles Therapeutics PLC ADR APLS Apellis Pharmaceuticals CERE Cerevel Therapeutics Holdings PHVS Pharvaris BV

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

25

$7.2 (40.45%)

29

26 days ago

5/8 (62.5%)

$7.16 (40.13%)

26

Buy

30

$12.2 (68.54%)

40

1 months 7 days ago

16/19 (84.21%)

$10.44 (53.37%)

184

Buy

39

$21.2 (119.10%)

40

1 months 23 days ago

6/10 (60%)

$15.25 (64.21%)

94

Buy

33

$15.2 (85.39%)

33

1 months 23 days ago

8/19 (42.11%)

$9.25 (38.95%)

119

Buy

36

$18.2 (102.25%)

1 months 23 days ago

0/1 (0%)

$12.25 (51.58%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

Which stock is Tazeen Ahmad is most bullish on?

Potential upside of $37.61 has been obtained for SRPT (SAREPTA THERAPEUTICS)

Which stock is Tazeen Ahmad is most reserved on?

Potential downside of -$11.74 has been obtained for PHVS (PHARVARIS BV)

What Year was the first public recommendation made by Tazeen Ahmad?

On 2012

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?